AAAAAA

   
Results: 1-11 |
Results: 11
Nitric oxide therapy for cardiovascular disease
Authors: Laight, DW
Citation: Dw. Laight, Nitric oxide therapy for cardiovascular disease, EXPERT OP T, 11(6), 2001, pp. 999-1005
Therapeutic approaches to insulin resistance
Authors: Laight, DW
Citation: Dw. Laight, Therapeutic approaches to insulin resistance, EXPERT OP T, 10(11), 2000, pp. 1703-1709
Investigation of endothelial hyperreactivity in the obese Zucker rat in-situ: reversal by vitamin E
Authors: Andrews, TJ Laight, DW Anggard, EE Carrier, MJ
Citation: Tj. Andrews et al., Investigation of endothelial hyperreactivity in the obese Zucker rat in-situ: reversal by vitamin E, J PHARM PHA, 52(1), 2000, pp. 83-86
Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo
Authors: Laight, DW Desai, KM Anggard, EE Carrier, MJ
Citation: Dw. Laight et al., Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo, EUR J PHARM, 402(1-2), 2000, pp. 95-99
Antioxidants, diabetes and endothelial dysfunction
Authors: Laight, DW Carrier, MJ Anggard, EE
Citation: Dw. Laight et al., Antioxidants, diabetes and endothelial dysfunction, CARDIO RES, 47(3), 2000, pp. 457-464
Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy
Authors: Laight, DW Carrier, MJ Anggard, EE
Citation: Dw. Laight et al., Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy, DIABET M R, 15(4), 1999, pp. 274-282
Physiological microassay of plasma total antioxidant status in a model of endothelial dysfunction in the rat following experimental oxidant stress invivo
Authors: Laight, DW Gunnarsson, PT Kaw, AV Anggard, EE Carrier, MJ
Citation: Dw. Laight et al., Physiological microassay of plasma total antioxidant status in a model of endothelial dysfunction in the rat following experimental oxidant stress invivo, ENV TOX PH, 7(1), 1999, pp. 27-31
Modulation of nitric oxide-dependent vascular and platelet function in-vitro by the novel phosphodiesterase type-V inhibitor, ONO-1505
Authors: Laight, DW Anggard, EE Carrier, MJ
Citation: Dw. Laight et al., Modulation of nitric oxide-dependent vascular and platelet function in-vitro by the novel phosphodiesterase type-V inhibitor, ONO-1505, J PHARM PHA, 51(12), 1999, pp. 1429-1433
F-2-isoprostane evidence of oxidant stress in the insulin resistant, obeseZucker rat: effects of vitamin E
Authors: Laight, DW Desai, KM Gopaul, NK Anggard, EE Carrier, MJ
Citation: Dw. Laight et al., F-2-isoprostane evidence of oxidant stress in the insulin resistant, obeseZucker rat: effects of vitamin E, EUR J PHARM, 377(1), 1999, pp. 89-92
Pro-oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat
Authors: Laight, DW Desai, KM Gopaul, NK Anggard, EE Carrier, MJ
Citation: Dw. Laight et al., Pro-oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat, BR J PHARM, 128(2), 1999, pp. 269-271
Pharmacological modulation of endothelial function by insulin in the rat aorta
Authors: Laight, DW Kaw, AV Carrier, MJ Anggard, EE
Citation: Dw. Laight et al., Pharmacological modulation of endothelial function by insulin in the rat aorta, J PHARM PHA, 50(10), 1998, pp. 1117-1120
Risultati: 1-11 |